Experiences from six years of quality assured Model of End Stage Liver Disease (MELD) diagnostics.
<h4>Background</h4>The model of end-stage liver disease (MELD) score was established for the allocation of liver transplants. The score is based on the medical laboratory parameters: bilirubin, creatinine and the international normalized ratio (INR). A verification algorithm for the labo...
Guardado en:
Autores principales: | Pascal Hunold, Thomas Berg, Daniel Seehofer, Robert Sucher, Adam Herber, Berend Isermann, Joachim Thiery, Thorsten Kaiser |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/baf9ed71c9b54be293dc592ecf794e10 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Raman spectroscopy on blood serum samples of patients with end-stage liver disease.
por: René Staritzbichler, et al.
Publicado: (2021) -
Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
por: Lau T, et al.
Publicado: (2013) -
Beyond MELD Predictors of Post TIPSS Acute Liver Failure the Lesson Learned
por: Ritu Verma, et al.
Publicado: (2021) -
MELD-accelerated molecular dynamics help determine amyloid fibril structures
por: Bhanita Sharma, et al.
Publicado: (2021) -
Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation.
por: Thiago Gomes Romano, et al.
Publicado: (2013)